PNPLA5
protein-codingpatatin like phospholipase domain containing 5, the group of Patatin like phospholipase domain containing
Gene summary
This gene is a member of the patatin-like phospholipase family; its encoded protein has been shown to inhibit transacylation. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Apr 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
No GenCC data available for this gene.
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PNPLA5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_138814.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 3 | 4 | |||
| missense | 70 | 3 | 3 | 76 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 71 | 4 | 6 | 81 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_620169.1 | 9 | MANE Select | |
| Ensembl | ENSP00000216177.3 | 9 | MANE Select | |
| RefSeq | NP_001171146.1 | 7 | Standard | |
| RefSeq | NP_001358339.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Metabolism of lipids
- Metabolism
- Triglyceride catabolism
- Triglyceride metabolism
Biological Process
- triglyceride catabolic process
- lipid homeostasis
Molecular Function
- triglyceride lipase activity
Cellular Component
- cytoplasm
- lipid droplet
- cytosol
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000216177
- Coding exons
- 9
- Length
- 12336
- Individuals with no LoFs
- 125595
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 153
- Defined
- 125748
- p
- 0.000609
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.353 | 241 | 226 | 1.07 | 0.0000125 | 2725 |
| Missense (PolyPhen) | 78 | 73.735 | 1.0578 | 892 | ||
| Synonymous | -0.00928 | 102 | 102 | 1.00 | 0.00000617 | 878 |
| Loss of Function | 1.40 | 12 | 18.5 | 0.648 | 7.95e-7 | 215 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0013 | 0.0012 | notable |
| Latino/Admixed American | 0.00026 | 0.00026 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00022 | 0.00022 | rare |
| Finnish | 0.0012 | 0.0012 | notable |
| European (Non-Finnish) | 0.00083 | 0.00079 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00067 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Lipid hydrolase. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.0945
Intolerance Scores
- LoFtool
- 0.799
- RVIS EVS
- 0.58
- RVIS percentile EVS
- 82.25
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.0704
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |